{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:53:19Z","timestamp":1773471199043,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.aohep.2022.100701","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T19:15:34Z","timestamp":1648322134000},"page":"100701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology"],"prefix":"10.1016","volume":"27","author":[{"given":"Jialu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.aohep.2022.100701_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.aohep.2022.100701_bib0002","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1016\/j.aohep.2022.100701_bib0003","first-page":"1","article-title":"PD-L1, TMB, and other potential predictors of response to immunotherapy for hepatocellular carcinoma: how can they assist drug clinical trials?","author":"Rizzo","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.aohep.2022.100701_bib0004","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.aohep.2022.100701_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/fon-2020-0986","article-title":"Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy","volume":"17","author":"Rizzo","year":"2021","journal-title":"Future Oncol"},{"issue":"6","key":"10.1016\/j.aohep.2022.100701_bib0006","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/hep.30528","article-title":"An efficient combination immunotherapy for primary liver cancer by harmonized activation of innate and adaptive immunity in mice","volume":"69","author":"Wen","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.aohep.2022.100701_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22071135","article-title":"How can synergism of traditional medicines benefit from network pharmacology?","volume":"22","author":"Yuan","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.aohep.2022.100701_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","article-title":"Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease","volume":"145","author":"Tao","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.aohep.2022.100701_bib0009","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3389\/fphar.2019.01185","article-title":"Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula Zuojin pill in suppressing hepatocellular carcinoma","volume":"10","author":"Guo","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2022.100701_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1142\/S0192415X20500093","article-title":"Integrating network pharmacology and experimental models to investigate the efficacy of coptidis and scutellaria containing huanglian jiedu decoction on hepatocellular carcinoma","volume":"48","author":"Huang","year":"2020","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.aohep.2022.100701_bib0011","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.923199","article-title":"A network pharmacology approach to explore the potential mechanisms of huangqin-baishao herb pair in treatment of cancer","volume":"26","author":"Xu","year":"2020","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.aohep.2022.100701_bib0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/0974-8490.182919","article-title":"Evaluating the anticancer potential of ethanolic gall extract of terminalia chebula (Gaertn.) Retz. (Combretaceae)","volume":"8","author":"Ravi Shankara","year":"2016","journal-title":"Pharmacognosy Res."},{"issue":"3","key":"10.1016\/j.aohep.2022.100701_bib0013","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0378-8741(02)00099-5","article-title":"Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit","volume":"81","author":"Saleem","year":"2002","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2022.100701_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.aohep.2022.100701_bib0015","first-page":"64","article-title":"The 'dnet' approach promotes emerging research on cancer patient survival","volume":"6","author":"Fang","year":"2014","journal-title":"Genome Med"},{"issue":"5","key":"10.1016\/j.aohep.2022.100701_bib0016","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"1","key":"10.1016\/j.aohep.2022.100701_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(87)90463-2","article-title":"Multimodal action of antitumor agents on DNA: the ellipticine series","volume":"259","author":"Auclair","year":"1987","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.aohep.2022.100701_bib0018","first-page":"707","article-title":"Phase II study of elliptinium in advanced breast cancer","volume":"69","author":"Rouesse","year":"1985","journal-title":"Cancer Treat Rep"},{"issue":"22","key":"10.1016\/j.aohep.2022.100701_bib0019","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.lfs.2005.10.041","article-title":"Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells","volume":"78","author":"Kuo","year":"2006","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.aohep.2022.100701_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.lungcan.2008.05.026","article-title":"Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells","volume":"63","author":"Fang","year":"2009","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.aohep.2022.100701_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103526","article-title":"Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6","volume":"21","author":"Yousuf","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.aohep.2022.100701_bib0022","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.aohep.2022.100701_bib0023","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/15548627.2019.1569934","article-title":"A novel role for ketoconazole in hepatocellular carcinoma treatment: linking PTGS2 to mitophagy machinery","volume":"15","author":"Chen","year":"2019","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.aohep.2022.100701_bib0024","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00438-014-0956-8","article-title":"Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis","volume":"290","author":"Sun","year":"2015","journal-title":"Mol Genet Genomics"},{"issue":"5","key":"10.1016\/j.aohep.2022.100701_bib0025","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.7150\/thno.49368","article-title":"CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF\/MET signaling","volume":"11","author":"Yu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.aohep.2022.100701_bib0026","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12935-019-0729-x","article-title":"MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1","volume":"19","author":"Gu","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"15","key":"10.1016\/j.aohep.2022.100701_bib0027","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1158\/1078-0432.CCR-20-0397","article-title":"Identification of a RAS-activating TMEM87A-RASGRF1 fusion in an exceptional responderto sunitinib with non-small cell lung cancer","volume":"26","author":"Cooper","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.aohep.2022.100701_bib0028","doi-asserted-by":"crossref","first-page":"262","DOI":"10.18632\/aging.100279","article-title":"RasGrf1 deficiency delays aging in mice","volume":"3","author":"Borras","year":"2011","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.aohep.2022.100701_bib0029","first-page":"3150","article-title":"The prognostic value of ADRA1 subfamily genes in gastric carcinoma","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"issue":"5","key":"10.1016\/j.aohep.2022.100701_bib0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcp.25650","article-title":"The Natural cAMP elevating compound forskolin in cancer therapy: is it time?","volume":"232","author":"Sapio","year":"2017","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.aohep.2022.100701_bib0031","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2174\/1381612825666190506122228","article-title":"The function of RAS mutation in cancer and advances in its drug research","volume":"25","author":"Chen","year":"2019","journal-title":"Curr Pharm Des"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268122000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268122000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:44:20Z","timestamp":1761648260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268122000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1665268122000436"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2022.100701","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2022.100701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100701"}}